当前位置: X-MOL 学术Antivir. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Baseline resistance-associated substitutions may impact DAA response among treatment failure chronic hepatitis C patients with pegylated interferon and ribavirin in real life.
Antiviral Therapy ( IF 1.3 ) Pub Date : 2020-09-16 , DOI: 10.3851/imp3369
Shan Ren 1 , Feili Wei 2 , Yi Jin 1 , Junfeng Lu 1 , Zhimin He 1 , Lina Ma 1 , Yanhong Zheng 1 , Junli Wang 1 , Xinyue Chen 1
Affiliation  

To evaluate the impact of baseline resistance-associated substitutions (RAS) on direct-acting antivirals (DAAs) treatment response among the pegylated interferon in combination with ribavirin (PR) failing patients in a real-life setting.

中文翻译:

在现实生活中,使用聚乙二醇化干扰素和利巴韦林治疗失败的慢性丙型肝炎患者中,基线耐药相关替代可能会影响 DAA 反应。

评估基线耐药相关替代 (RAS) 对聚乙二醇干扰素联合利巴韦林 (PR) 治疗失败患者在现实生活环境中的直接作用抗病毒药物 (DAA) 治疗反应的影响。
更新日期:2020-09-18
down
wechat
bug